top of page

Tieteelliset tutkimukset mRNA:sta

Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis

Cardiac

Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse, a case report

Cardiac

Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent

Cardiac

Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent

Cardiac

Recurrent Kounis syndrome - a life-threatening event after COVID-19 vaccine administration

Cardiac

Recurrent MRI-Documented Myocarditis Following Pfizer-BioNTech SARS-CoV-2 Vaccinatio

Cardiac

Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine

Cardiac

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Cardiac

Myocarditis following J&J in a healthy, young male

Cardiac

Myocarditis following mRNA COVID-19 vaccination, call for endomyocardial biopsy

Cardiac

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series

Cardiac

Myocarditis Following the Second Dose of COVID-19 Vaccination in a Japanese Adolescent

Cardiac

Myocarditis in 13-Year-Old Monochorionic Diamniotic Twins After COVID-19 Vaccination

Cardiac

Myocarditis in adolescents and adults following vaccination in 2021, review of 238 cases

Cardiac

Myocarditis in children after COVID-19 vaccine

Cardiac

Myocarditis in the Setting of Recent COVID-19 Vaccination

Cardiac

Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccine

Cardiac

Myocarditis and or pericarditis after mRNA vaccination, head to head comparison of Moderna versus Pfizer

Cardiac

Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines

Cardiac

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination, Practical Considerations for Care Providers

Cardiac

bottom of page